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Abstract Non-targeted screening of drugs present in her-
bal products, known as ‘‘legal high’’ drugs and in hair as a
biological matrix commonly used in toxicological investi-
gations was accomplished with the use of high pressure
liquid chromatography coupled with quadrupole time-of-
flight mass spectrometry (HPLC-Q-TOF-MS). In total, 25
and 14 therapeutical drugs and psychoactive substances/
metabolites were detected in investigated hair samples and
herbal products, respectively. We demonstrate that the
HPLC-Q-TOF methodology seems to be a powerful tool in
the qualitative analysis applied in identification of these
designer drugs, thus enabling a laboratory to stay-up-to-
date with the drugs that are being sold as legal high
products on black market.
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Introduction
The identification of large number of new continuously and
increasingly appearing designer drugs on drug market is
currently a major priority for forensic laboratories [1, 2].
Due to the novelty of incoming psychoactive products
known as ‘‘legal highs’’ or ‘‘herbal highs’’, at present there
is limited research in the published literature concerning
the pharmacokinetics, pharmacological or toxicological
effects of these drugs [3]. Control of production and dis-
tribution of new emerging legal highs is strongly dependent
on implementation of new screening methods and analyt-
ical solutions. The identification of psychoactive
substances is challenging due to their fast transience on the
drug scene.
Recently, many analytical techniques have been applied
in comprehensive drug screening in biological and non-
biological specimens. Application of routine toxicological
methods based on the use of immunochemical assays is
limited mainly due to their insufficient sensitivity and
limited coverage. Their use is also hampered by the risk of
obtaining false positive results, what can lead to serious
medical and social consequences [4, 5]. Therefore, high
performance liquid chromatography coupled with high
resolution TOF (or Q-TOF) mass spectrometry is mostly
applied. HPLC-Q-TOF-MS technique enables tentative
identification of unknown compound based on prediction
of chemical formula from accurate ion mass measurement
and characteristic isotopic pattern [6]. Moreover, the vol-
ume of sample required for analysis is very small [7].
Therefore, it is stated as a very powerful tool for identifi-
cation of species and can be very useful when reference
standards are not available. Moreover, it provides excellent
full-scan sensitivity, that makes it suitable for wide-scope
screening in forensic investigations. The successful
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application of Q-TOF-MS technique in screening of many
different families of drugs has been reported by many
researchers [5, 6, 8–10].
The availability of the legal high products on the black
market, in various forms of preparations like powders,
pills, and teas is increasing tremendously. These products
are easily available in herbal shops. Moreover, they are
intaken as an alternative for federally illegal amphetamines
or opioids [4, 11].
In the last decades, hair analysis has become a well
established strategy to investigate retrospectively drug
abuse histories [4]. Hair, as a human matrix, exhibit a lot of
highlights in drug of abuse analysis compared to other
biological samples (blood or urine) [12]. Firstly, sampling
step for hair is non-invasive, simple, and painless for the
patient. Secondly, hair sample does not require any special
storage and transport conditions due to slow process of hair
destruction in comparison to another biological samples
[13]. Besides, drugs can stay in this matrix for a long time
(even months). However, hair samples have got some
limitations for analysts, just to mention time-consuming
analytical procedures and high correlation to melanin
concentration dramatically affecting results [14]. In short,
what is the most important, hair allows to retrospective
detection of chronic exposure to drugs or poisons up to
years back. Hair analysis consists of few principal steps:
sampling, storage and transport, decontamination, extrac-
tion of features from biological matrix, instrumental
analysis, and finally data interpretation. The decontami-
nation phase involves of one or washings of the sample to
eliminate possible external contamination. The extraction
of the analytes from the hair can be achieved by various
methods, which differ according to the nature of the ana-
lytes themselves and the identification technique to be
employed [15].
The purpose of this paper was to investigate the capa-
bility of high pressure liquid chromatography coupled with
quadrupole time-of-flight mass spectrometry for rapid
screening of representative multiclass drugs including
antidepressants, non-narcotic, antibiotics, or illegal drugs
such as opioids and amphetamines in herbal products and
hair samples taken as the one of the most commonly used
as biological matrices. The high sensitivity obtained in full-
scan MS mode allows to the retrospective detection of
unknown compounds. Our aim was to present the overall
concept of application of Q-TOF technique in two areas of
toxicological screening: firstly, detection of chronic intake
of therapeutical drugs and illegal substances in 13 hair
samples obtained from volunteers, former addicts and
secondly to evaluate the presence of federally controlled
active substances in four commercially illegal highs prod-
ucts investigated under this study.
Results and discussion
The automatic screening and identification of drugs present
in hair and herbal products were based on the use of narrow
mass window (±5 ppm) for (pseudo)molecular ion and
utilization of isotope fit. Justification of the accurate masses
of unknown compound fragments generated in MS tandem
mode was additionally supported by its chemical structure
and comparison of data previously reported in the litera-
ture. Additionally, identification of particular drug was
facilitated by the use of commercially available NIST 2.0
Software with in-house database containing 885 com-
pounds of forensic relevance. In case of failure searching of
in-house personal compound database, screening of
unknown species was accomplished with use of on-line
databases, such as: METLIN, Mass Bank, ChemSpider,
and PubChem. The overall workflow for the identification
of compounds with use of METLIN’s Metabolite spectral
database and MassBank database is presented in Figs. 1, 2,
respectively.
Identification of compounds based only on accurate
mass measurement can lead to false positive results (in case
of isobaric compounds); therefore, Target MS/MS mode
was necessarily performed to obtain the fragmentation
spectra of selected compounds and elucidate their possible
structures. The overall concept of elucidation the structure
of compound based on MS/MS spectrum was present using
identification of methoxetamine in hair samples as an
example (Fig. 3). Elemental composition analysis within
the set criteria with use of MassHunter software generated
a compound with m/z = 248.1646 with chemical formula
C15H21NO2. The elemental composition indicates that this
compound might be ethylphenidate or methoxetamine. The
fragmentation of the particular compound by MS/MS
provided four main fragment ions at m/z = 203.1069,
175.1116, 121.0651, and 67.0541. Observed fragments and
comparison of supporting information from databases
confirmed the fact that methoxetamine is predicted com-
pound. It strongly reduces the number of unknown
compounds to a single structure. A summary of the psy-
choactive substance detected in dried plant material and
hair samples is shown in Tables 1, 2, respectively. In total,
the inspection of the accurate mass MS total ion chro-
matogram (TIC) indicate the presence of 14 compounds in
investigated legal high products and 25 in hair samples,
respectively.
The Controlled Substances Act (CSA) regulates import,
possession, use, and distribution of certain substances. The
legislation includes five schedules, that are describing the
characteristics of each substance. Talbutal, as intermediate-
acting barbiturate, belongs to substances controlled in
Schedule III, which use can lead to moderate and psychical
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dependence. Synthetic cannabinoid compounds, such as
UR-144, AKB-48, JWH-016, JWH 369 and synthetic
stimulants, like mephedrone have been controlled by
United States Drug Enforcement Agency under Schedule I
(drugs with high potential of abuse) [16]. As can be seen in
Table 1 federally controlled compounds were detected in
commercially and easily available legal herbal products.
After legislation and registration processes the use of these
controlled substances is unexpectedly not waned, what
confirms and enforces of the necessity of qualitative
identification of this type of products in order to enable
forensic laboratories to be ‘‘on time’’ with current drugs
and its possible replacements being sold as designer
products.
In the 13 hair samples, 21 therapeutic and illegal drugs
were identified. This included mainly: sedative hypnotic
drugs (zopiclone), antitussives (dextromethorphan,
dimethyltryptamine), antidepressants (fluoxetine, doxepin),
antihistaminics (hydroxyzine), non-narcotic analgesics
(methadone, fentanyl, paracetamol), antibiotics (sul-
famethoxazole, trimethoprim), antipsychotics (perazine),
adulterants (hydroxyperazine), narcotic analgesics (a-tra-
madol), medications for treatment of cardiovascular
diseases (metropolol), nootropics (noopept), stimulants and
psychedelics (6-APB, 6-APBD, a-methyltryptamine) and
illegal drugs such as opioids (methadone), amphetamines
(amphetamine), cannabinoids (UR-144), cathinones
(methoxetamine). The results are summarized in Table 2.
Fig. 1 Steps in the identification of unknown compound with the use of METLIN database. Example was presented for talbutal detected in
herbal product
Fig. 2 Steps in the identification of unknown compound with the use of MassBank database. Example was presented for mephedrone detected in
herbal product
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Additionally, metabolites of tramadol, namely O-
desmethyltramadol and N-desmethyltramadol as well as
metabolites of doxepin- hydroxydoxepin and desmethyl-
doxepin were found in hair samples. Due to similarity in
doxepin structure (m/z = 280.1696) and desmethyldoxepin
(m/z = 266.1539) these analytes were eluted at the same
time. The intensity of hydroxydoxepin peak is higher than
the intensity of doxepin peak, what can be a proof for
higher incorporation of this metabolite in hair structure
than other features. Despite the large advantages of use of
HPLC-Q-TOF-MS technique for the screening of drugs in
hair, there were 22 drugs and psychoactive substances
mentioned in volunteer’s questionnaires but were not
detected in the hair samples. The details were summarized
in Table 3.
Few reasons can be given to explain this phenomena.
Firstly, low incorporation rate of drugs in hair, which can
be affected by washing-out by shampooing and hair pig-
mentation (sample III). It is well known, that the
incorporation of drugs in the hair depends on melanin
content in the matrix and is regulated by the pharmaco-
logical principles of the substance distribution. The
incorporation and binding of drugs in the hair are much
greater in pigmented versus non-pigmented hair, so no
detection of these drugs in gray hair is explicable [13]. The
reason can also lie in irregular intake of drugs (sample IX),
insufficient stability of features in hair, a long-term medical
treatment in case of some drugs and finally low concen-
tration of drug in hair sample which is not sufficient for
Q-TOF-MS detection (sample VIII). In case of sample IX,
hair were collected from tip (distal) section of hair as well.
This additional analysis was performed in order to verify
how cutting/not-cutting of hair for 5 years (as was declared
in questionnaire) will affect results. This effort allowed to
detect 6-APB (this drug was not detected in hair sample
taken from posterior vertex of the head), what confirms
hypothesis that this drug was intaken in earlier period of
life.
Fig. 3 Steps in the
identification of methoxetamine
in hair samples by HPLC-Q-
TOF-MS/MS: a MS/MS
spectrum of ion at
m/z = 248.1646; b generated
chemical formula at





m/z = 248.1646; calculated
mass [M?H]: 248.1645;
c proposed fragmentation of
methoxetamine
1410 J. Aszyk, A. Kot-Wasik
123
Conclusions
In this study, a HPLC method coupled with Q-TOF-MS for
the toxicological screening and identification of 39 drugs
and metabolites in herbal products and hair samples was
developed. The proposed HPLC-Q-TOF method based
both on accurate mass, isotopic pattern recognition and
fragmentation spectra obtained in Targeted MS/MS mode
has been successfully applied to hair samples from 13
abusers with known therapeutic and psychoactive drug
intake at the life time and 4 herbal legal high products.
Positive and negative ion mode was applied in order to
increase sensitivity for basic and acidic analytes. The
sample preparation including basic incubation followed by
liquid–liquid extraction with ethyl acetate was suitable for
variety of substances present in investigated hair samples.
Despite the large advantages of HPLC-Q-TOF-MS tech-
nique in comprehensive forensic investigations, a
disagreement between substances mentioned in question-
naires and detected in hair in some cases was observed.
The developed HPLC-Q-TOF-MS method provides to be
applicable in comprehensive forensic investigations,
depending on the aim of the research: (1) introducing a
legislation and restriction according to new federally
uncontrolled substances detected in so called ‘‘legal highs’’,
(2) studies on mechanism of action, diffusion among
selected populations of drug abusers as well as metabolism
of novel psychoactive substances based on their detection in
biological specimens, such as hair samples.
Further investigations to improve results obtained in
qualitative screening should mainly focus on performance
of semi-quantitative determination of detected drugs.
Experimental
Chemicals
Acetonitrile, methanol, ammonium formate (LC–MS
grade) were purchased from Sigma-Aldrich (St. Louis,
USA). Formic acid (FA) was purchased from Merck
(Darmstadt, Germany). Acetone and hexane (analytical
grade) were purchased from POCH (Gliwice, Poland).
Sodium hydroxide, ethyl acetate, and hydrochloric acid
(analytical grade) were obtained from POCH (Gliwice,
Poland). Nylon (PA) ProFillTM 25 mm bright blue (0.2 lm
pore size) syringe filters Whatman PuradiscTM 13 mm
PTFE (0.2 lm pore size) syringe filters were purchased
from Sigma-Aldrich (St. Louis, USA). Ultrapure H2O was
prepared using HLP5 system from Hydrolab (Wis´lina,
Poland).
Herbal products collection and preparation
The research collaborator collected four samples of legal
high products available and sold on the drug market over
the Internet under the names of ‘‘Tajfun’’, ‘‘The recidivist’’,
‘‘R.I.P.’’, and ‘‘The Bandit’’. For toxicological screening
Table 1 Summary of drug detected in herbal products and their theoretical and experimental masses
Product name Compounds detected Chemical formula m/z value Dm/ppm
Measured Calculated
Tajfun Mephedrone C11H15NO 178.1224 178.1226 1.12
Talbutal C13H20N2O3 253.1540 253.1547 2.76
JWH-016 C24H23NO 343.2767 343.2780 3.46
JWH-369 C26H24ClNO 401.1867 401.1546 1.74
The recidivist Ropinirole C16H24N2O 261.1965 261.1961 1.53
SB-206553 C17H16N4O 293.1814 293.1808 2.05
UR-144 C21H29NO 312.2327 312.2322 1.60
Cocaethylene C18H23NO4 318.1689 318.1700 3.46
Perazine C20H25N3S 340.1846 340.1842 1.18
R.I.P. Ethylketocyclazocine C19H25NO2 300.1966 300.1958 2.66
UR-144 C21H29NO 312.2312 312.2322 3.20
Perazine C20H25N3S 340.1847 340.1842 1.47
AKB-48 C23H31N3O 366.2553 366.2540 3.55
The Bandit Clorgiline C13H15Cl2NO 272.0598 272.0603 1.84
Cocaethylene C18H23NO4 318.1690 318.1700 3.14
Propoxyphene C22H29NO2 340.2284 340.2271 3.82
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50 mg of dried herbal material was used. Subsequently,
5 cm3 of solvent mixture ACN:MeOH (1:1) was added and
the content was vortex mixed for 10 min. The mixture was
sealed with aluminum for protection from light and left for
72 h in darkness. After incubation content was mixed for
2 min and consecutively filtered through syringe filters
(0.2 lm pore size). Prior to analysis solution was diluted
1:100 with acetonitrile/water mixture (3:7). Subsequently it
was transferred into autosampler vial. 10 mm3 were
injected for Q-TOF-MS analysis.
Hair sample collection and preparation
Hair samples (n = 13) were collected from the posterior
vertex region of volunteers. Additionally, control hair
samples were taken for analytical purposes from persons
who do not declare drug intake to verify potential inter-
ferences coming from the hair matrix. The hair samples
were stored in low-density polyethylene Zipper bags at
20–25 C until the analysis. Before sample preparation hair
sample (approx. 200 mg) was cut into small pieces. Then,
Table 2 Summary of drug detected in hair samples and their theoretical and experimental masses
Compounds detected Chemical formula m/z value Dm/ppm
Measured Calculated
6-APB C11H13NO 176.1069 176.1070 0.57
6-APDB C11H15NO 178.1230 178.1226 2.25
Amphetamine C9H13N 136.1124 136.1121 2.20
Dextromethorphan C18H25NO 272.2009 272.1998 4.04
Dimethyltryptamine C12H16N2 189.1382 189.1386 2.11
Doxepin C19H21NO 280.1692 280.1696 1.43
Desmethyldoxepin C18H19NO 266.1542 266.1539 1.13
Hydroxydoxepin C19H21NO2 296.1652 296.1645 2.36
Fentanyl C22H28N2O 337.2267 337.2274 2.08
Fluoxetine C17H18F3NO 310.1415 310.1413 0.64
Hydroxyzine C21H27ClN2O2 375.1830 375.1834 1.07
Methadone C21H27NO 310.2170 310.2165 1.61
Methoxetamine C15H21NO2 248.1646 248.1645 0.40
a-Methyltryptamine C11H14N2 175.1231 175.1230 0.57
Metropolol C15H25NO3 268.1899 268.1907 2.98
Noopept C17H22N2O4 319.1656 319.1652 1.25
Paracetamol C8H9NO2 152.0704 152.0706 1.32
Perazine C20H25N3S 340.1833 340.1842 2.65
Sulfamethoxazole C10H11N3O3S 254.0590 254.0594 1.57
a-Tramadol C16H25NO2 264.1951 264.1958 2.65
O-Desmethylotramadol C15H23NO2 250.1799 250.1801 0.80
N-Desmethylotramadol C15H23NO2 250.1799 250.1801 0.80
Trimethoprim C14H18N4O3 291.1447 291.1452 1.72
Zopiclone C17H17ClN6O3 389.1120 389.1123 0.77
UR-144 C21H29NO 312.2310 312.2322 3.84
Table 3 Summary of analyzed hair samples with undetected substances
Subject no. X Color of hair Undetected substances Additional information
III Gray Tolterodine Washing hair at least one time per day
VIII Dark blonde Morphine -
IX Dark blonde AM-2201, codeine, ephedrine, 4-AcO-DMT, methandienone, GBL,
2C-B, dimenhydrinate, 25C-NBOMe, 4-FMA, 5-Meo-MiPT
Not cutting hair for 5 years
XIII Middle blonde Ergine, 5-API, ethylphenidate, 2C-P, MAM-2201, 25C-NBOMe,
MDMA, 25I-NBOMe, 5-HO-DMT
-
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the decontamination of the hair was performed in water
bath by gentle shaking of hair for 1 min in 10 cm3 of n-
hexane followed by shaking in 10 cm3 of acetone for
1 min. After hair drying on a filter paper (up to 10 min)
samples were cut to 1–2 cm pieces and homogenized. In
order to choose the most appropriate extraction method
three procedures were compared: (1) 18 h incubation at
50 C in MeOH in ultrasonic bath, (2) 8 h incubation at
50 C in MeOH/ACN (1:1) in ultrasonic bath, and (3) 18 h
incubation at 50 C in 2.5 M NaOH. Evaluation of the
most appropriate extraction method was done based on the
relative comparison of the number of extracted substances
from real hair samples or/and their chromatographic peak
intensity using different extraction methods. Alkalic incu-
bation was selected as optimal extraction method due to the
fact, that it allows to extract the largest number of psy-
choactive substances relative to another tested methods
from all investigated hair samples. It presumptively
allowed to liberate contained xenobiotics. Optimized
extraction conditions were as follows: after decontamina-
tion step, hair samples were incubated in 5 cm3 2.5 M
NaOH at 50 C for 18 h and extracted in separator with
5 cm3 of ethyl acetate. After extraction, followed by cen-
trifugation at 6000 rpm, organic phase was collected and
the excess of solvent was evaporated under a gentle stream
of nitrogen at 40 C. The residue was reconstituted in a
mixture of H2O and MeOH with 0.05 % FA (50:50, v/v) It
is worth to mention that the colloid formation was recorded
after 2 days of extract storage at room temperature. Finally,
10 mm3 of the extract was injected to perform HPLC-ESI-
Q-TOF-MS analysis. Overall workflow for the identifica-
tion of drugs and psychoactive substances in hair sample
has been shown in the Fig. 4.
Instrumentation
The HPLC-Q-TOF-MS was performed with the use of an
Agilent 1290 LC system equipped with a binary pump, an
online degasser, an autosampler and a thermostated column
compartment coupled with a 6540 Q-TOF-MS with a Dual
ESI source (Agilent Technologies, Santa Clara, CA, USA).
An Agilent ZORBAX XDB-C-8, 150 9 4.6 mm, 3.5 lm
column was used for RP-HPLC separation of extracts
obtained from hair samples and herbal products with gra-
dient elution program from 10 to 100 % B during 20 min
followed by 100 % B maintained for 5 min. The mobile
phase flow rate was 0.5 cm3/min and injection volume in
this case was 10 mm3. The mobile phase consisted of water
Fig. 4 Workflow for identification of xenobiotics in hair sample
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containing 0.01 % formic acid (component A) and
methanol containing 0.01 % formic acid (component B).
The column temperature throughout the separation process
was kept at 40 C. During all analyses, the samples were
kept in an autosampler at 4 C.
The ESI source was operated both in positive and neg-
ative ion mode with the following conditions: the
fragmentor voltage was set at 120 V, nebulizer gas was set
at 35 psig, capillary voltage was set at 3500 V, and drying
gas flow rate and temperature were set at 10 dm3/min and
300 C, respectively. For MS/MS measurements collision
energy ramp ranging from 15 to 40 eV to promote frag-
mentation was used. The data were acquired in centroid
and profile mode using High Resolution mode (4 GHz).
The mass range was set at 50-1000 m/z in MS and MS/MS
mode. The data were processed with the MassHunter
Workstation QualitativeAnalysis.B.03.01 Software. The
Q-TOF-MS was calibrated on a daily basis.
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